High prolactin levels as a worsening factor for migraine

Journal of Headache and Pain

Volumn 7, Issue 2, 2006, Pages 83-89

  Cavestro, Cinzia ^a   Rosatello, Annalisa ^b   Marino, Maria Pia ^b   Micca, Gianmatteo ^b   Asteggiano, Giovanni ^b  

^a S Lazzaro Hospital   (Italy)

^b Ospedale S Lazzaro   (Italy)

Author keywords

Chronic headache; Chronic migraine; Hyperprolactinaemia; Prolactin

Indexed keywords

CABERGOLINE; ESTROGEN; GESTAGEN; PROLACTIN;

ADOLESCENT; ADULT; AMENORRHEA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GALACTORRHEA; HORMONE DETERMINATION; HUMAN; MENSTRUAL IRREGULARITY; MIGRAINE WITHOUT AURA; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; RISK FACTOR; TENSION HEADACHE; TRANSFORMED MIGRAINE; TREATMENT RESPONSE; AGED; COMPARATIVE STUDY; FLUORESCENT ANTIBODY TECHNIQUE; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MIGRAINE; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PROLACTIN; PROSPECTIVE STUDIES;

EID: 33745984827     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-006-0272-8     Document Type: Article

References (32)

1. D'Andrea G, Perini F, Terrazzino S, Nordera GP (2004) Contributions of biochemistry to the pathogenesis of primary headaches. Neurol Sci 25[Suppl 3]:S89-S92
2. Welch KMA (2004) Research developments in the physiopathology of primary headaches. Neurol Sci 25[Suppl 3]:S97-S103
3. Silberstein SD, Meriam GR (1993) Sex hormones and headache. J Pain Symptom Manage 8:98-114
4. Drummond PD, Lance JW (1984) Neurovascular disturbances in headache patients. Clin Exp Neurol 20:93-99
5. Rasmussen BK, Olesen J (1992) Migraine with aura and migraine without aura: An epidemiological study. Cephalalgia 12:221-228
6. Nappi G, Martignoni E, Bono G, Savoldi F, Murialdo G, Polleri A (1981) THDA system function in migraine. In: Rose C, Zilkha KJ (eds) Progress in migraine research 1. Pitman, London, p. 110-123
7. Polleri A, Nappi G, Murialdo G, Martignoni E, Sances G, Zauli C, Savoldi F (1984) THDA neuron impairment and oestrogen receptor modulation in headache. In: Rose FD (ed) Progress in migraine research 2. Pitman, London pp. 205-215
8. Murialdo G, Martignoni E, Maria AD, Bonura ML, Sances G, Bono G, Polleri A (1986) Changes in the dopaminergic control of prolactin secretion and in ovarian steroids in migraine. Headache 26:9-12
9. Bussone G, Frediani F, Lamperti E, LaMantia L, Vescovi A, Peccarisi C, Boiardi A (1986) Piribedil test in migraine: Neuroendocrinological aspects. Headache 26:482-485
10. Nattero G, Corno M, Savi L, Isaia GC, Priolo C, Mussetta M (1986) Prolactin and migraine: Effect of L-dopa on plasma prolactin levels in migraineurs and normal. Headache 26:9-12
11. Awaki E, Takeshima T, Takahashi K (1998) A neuroendocrinological study in female migraineurs: Prolactin and thyroid stimulating hormone responses. Cephalalgia 9:187-193
12. Forsyth PA, Posner JB (1993) Headaches in patients with brain tumour - a study of 111 patients. Neurology 43:1678-1683
13. Suwanwela N, Phanthumchinda K, Kaoropthum S (1994) Headache in brain tumour: A cross-sectional study. Headache 34:435-438
14. Levy MJ, Jager HR, Matharu MS, Goadsby PJ (2002) Pituitary tumours and headache: Does size matter? Cephalalgia 22:592
15. Ferrari MD, Haan J, van Seters AP (1988) Bromocriptine induced trigeminal neuralgia attacks in patients with pituitary tumour. Neurology 38:1482-1484
16. Massiou H, Launay JM, Levy C, El Amran M, Emperauger B, Bousser MG (2002) SUNCT syndrome in two patients with prolactinomas and bromocriptin-induced attacks. Neurology 58:1698-1699
17. Levy MJ, Matharu MS, Goadsby PJ (2003) Prolactinomas, dopamine agonists and headache: Two case reports. Eur J Neurol 10:169-173
18. Peres MFP, Siow HC, Rozen TD (2002) Hemicrania continua with aura. Cephalalgia 22:246-248
19. Waldenlind E, Gustafsson SA (1987) Prolactin in cluster headache: diurnal secretion, responses to thyrotropin-releasing hormone, and relation to sex steroids and gonadotropins. Cephalalgia 7:43-54
20. Polleri A, Nappi G, Murialdo G, Bono G, Martignoni E, Savoldi F (1982) Changes in the 24-hour prolactin pattern in cluster headache. Cephalalgia 2:1-7
21. Stoupel E (2002) The effect of geomagnetic activity on cardiovascular parameters. Biomed Pharmacother 56[Suppl 2]:247S-256S
22. Stoupel E (2000) Application of phototherapy in children with headache. Zh Nevrol Psikhiatr Im S S Korsakova 100:40-42
23. Headache Classification Subcommittee of The International Headache Society (2004) The International Classification of Headache Disorders, 2nd edition. Cephalalgia 24[Suppl 1]:1-160
24. Mah PM, Webster J (1999) Hyperprolactinemia: Etiology, diagnosis, and management. Semin Reprod Res 35:S67-S73
25. Matharu MS, Levy MJ, Merry RT, Goadsby PJ (2003) SUNCT syndrome secondary to prolactinoma. J Neurol Neurosurg Psychiatry 74:1590-1592
26. Richman PB, Allegra J, Eskin B et al (2002) A randomised clinical trial to assess the efficacy of intramuscular droperidol for treatment of acute migraine headache. Am J Emergency Med 20:39-42
27. Nagel-Leiby S, Welch KMA, D'Andrea G, Grunfeld S, Brown E (1990) Event-related slow potentials and associated catecholamine function in migraine. Cephalalgia 10:317-329
28. Pascual J, Freijares J, Berciano J, Pesquera C (1991) Analgesic effect of octreotide in headache associated with acromegaly is not mediated by opioid mechanisms. Pain 47:341-344
29. Sicuteri F, Geppetti P, Marabini S, Lembeck F (1984) Pain relief by somatostatin in attacks of cluster headache. Pain 18:359-365
30. Otsuka F, Kageyama J, Ogura T, Makino H (1998) Cluster headache dependent upon ostreotide injection. Headache 38:629
31. Kapicioglu S, Gokce E, Kapicioglu Z, Ovali E (1997) Treatment of migraine attacks with a long acting somatostatin analogue (octreotide, SMS 201-995). Cephalalgia 17:27-30
32. Mah PM, Webster J (2002) Hyperprolactinemia: Etiology,diagnosis, and management. Semin Reprod Med 20:365-374